Emilio Attena to Atrial Fibrillation
This is a "connection" page, showing publications Emilio Attena has written about Atrial Fibrillation.
Connection Strength
0.338
-
Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational study. Eur J Clin Invest. 2020 Dec; 50(12):e13387.
Score: 0.076
-
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study. Clin Ther. 2019 08; 41(8):1598-1604.
Score: 0.069
-
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study. Biomed Res Int. 2019; 2019:5473240.
Score: 0.068
-
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience. Semin Thromb Hemost. 2018 Jun; 44(4):364-369.
Score: 0.063
-
Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review. Semin Thromb Hemost. 2018 Jun; 44(4):370-376.
Score: 0.062